Geneos Wealth Management’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History
Bought
Maintained
Sold
Other funds holding TCAF
Geneos Wealth Management's TCAF Position: Q3 2026 in Review
Geneos Wealth Management increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 23% in Q3 2026, buying an estimated $47.4K and bringing the position to 6,062 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #995.
Geneos Wealth Management first reported a position in TCAF in Q1 2025 and has held it in 7 quarters since. 369 funds tracked by Wall St. Rank hold TCAF as of Q3 2026.
- Geneos Wealth Management held 6,062 shares of T. Rowe Price Capital Appreciation Equity ETF worth $256K as of Q3 2026.
- Geneos Wealth Management bought 1,124 T. Rowe Price Capital Appreciation Equity ETF shares in Q3 2026, an estimated $47.4K.
- T. Rowe Price Capital Appreciation Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #995 holding.
- Geneos Wealth Management first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q1 2025 and has held it in 7 quarters since.
- 369 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q3 2026.
Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.